Abexinostat
Renal Cell Carcinoma (Kidney Cancer)
Phase 3Active (Pivotal trial, first patient dosed in China)
Key Facts
Indication
Renal Cell Carcinoma (Kidney Cancer)
Phase
Phase 3
Status
Active (Pivotal trial, first patient dosed in China)
About Xynomic Pharmaceuticals
A clinical-stage oncology biotech in-licensing and developing novel small molecule therapies for global markets, with a lead asset in pivotal trials.
View full company profileAbout Xynomic Pharmaceuticals
A clinical-stage oncology biotech in-licensing and developing novel small molecule therapies for global markets, with a lead asset in pivotal trials.
View full company profile